Fusionex International PLC GIANT contract win with Asian hospital (6591L)
January 13 2016 - 2:00AM
UK Regulatory
TIDMFXI
RNS Number : 6591L
Fusionex International PLC
13 January 2016
For Immediate Release 13 January 2016
Fusionex International plc
("Fusionex" or "the Group")
GIANT contract win with Asian hospital
Fusionex, an international provider of software specialising in
Analytics, Big Data and the Internet of Things ("IoT"), is
delighted to announce that it has secured its first win for its Big
Data Analytics software, Fusionex Insights (GIANT), in the
fast-growing medical analytics market.
The contract is with a multi-facility hospital, based in Asia,
which provides medical and rehabilitative services ranging from
dermatology to psychiatry, nephrology, cardiology and
rheumatology.
With a customer charter that promises safe and quality patient
care, the hospital's processes and procedures are set to take a
leap into the data-driven age with Fusionex GIANT. Using GIANT to
compile a personalised database of patients is a key benefit for
the client, as its legacy systems can no longer cope with the
number, variety, nor the complexity, of patient cases and profiles.
Furthermore, personalised databases offer better insights for
doctors to recommend and prescribe treatments for patients even
before they are admitted.
In addition, the connecting of various medical instruments and
appliances via IoT helps record machine usage, manage costs and
prevent misuse. As the hospital has an internal KPI of treating
critical cases immediately and semi-critical cases within 30
minutes, the usage of Fusionex GIANT will help optimise staff
efficiency levels to ensure that sufficient medical officers are on
standby without affecting staff morale or costs.
To keep up with the spread of infections and stem outbreaks
before they happen, Fusionex GIANT will also be used to provide the
insight and foresight needed to track disease transmission among
patients. The risks associated with that such as the recent Ebola
virus in West Africa will be better managed with better data
management. Furthermore, Fusionex's high levels of data security
will enhance and protect the handling of patients' sensitive
data.
Servicing a booming population, Big Data Analytics tools such as
biometrics are a key means towards better understanding patients
and their ailments. Moreover, they also afford doctors and the
hospitals the ability to identify patterns among patients of
similar attributes, symptoms, demographics as well as find
important correlations to make more well informed / suitable
prescriptions. As this contract demonstrates, Fusionex is well
placed to benefit from the fast-growing uptake of Big Data
Analytics in the healthcare market, with GIANT providing actionable
insights in a user-friendly, easy-to-understand format.
Ivan Teh, Fusionex Chief Executive Officer, commented:
"The client is committed towards serving a growing populace by
employing innovative equipment and technologies. We are thrilled to
be working with them to make the most of their data and make a
bigger impact in the ever-evolving healthcare industry.
This win by Fusionex GIANT demonstrates the efficacy and value
of advanced analytics as well as the Internet of Things to
businesses. We anticipate more success stories in the healthcare
industry which continues to be an important sector of focus where
efficiency, diagnostic, predictive and prescriptive analytics are
concerned."
For further details:
Fusionex Through Buchanan
Ivan Teh, Chief Executive Officer
Yuen Choong Lai, Chief Financial Officer
Darren Hopkins, Director for IR and Corporate Development
Panmure Gordon
Fred Walsh, Alina Vaskina (Investment Banking)
Erik Anderson, Tom Nicholson, Charles Leigh-Pemberton (Corporate Broking) 020 7886 2500
RBC Capital Markets
Pierre Schreuder, Ema Jakasovic 020 7653 4000
Buchanan
Sophie McNulty, Gabriella Clinkard, Stephanie Watson
www.buchanan.uk.com 020 7466 5000
This information is provided by RNS
The company news service from the London Stock Exchange
END
CNTDLLFFQFFXBBV
(END) Dow Jones Newswires
January 13, 2016 02:00 ET (07:00 GMT)
Fusionex (LSE:FXI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fusionex (LSE:FXI)
Historical Stock Chart
From Jul 2023 to Jul 2024